BackASLAN Pharmaceuticals Overview

ASLAN Pharmaceuticals Accounts Payable

Latest accounts payable for ASLN: $9.7M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$9.66M
3.64% YoYΔ $-364874.00 vs prior year quarter

Peer average

Loading

ASLAN Pharmaceuticals Accounts Payable History

Loading

ASLAN Pharmaceuticals vs. peers: Accounts Payable Comparison

Loading

ASLAN Pharmaceuticals Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

ASLAN Pharmaceuticals (ASLN) FAQ

As of the most recent data (March 2024), ASLN shows a accounts payable of $9.7M. That compares with $10M in the prior-year period — down 3.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ASLN's accounts payable is now $9.7M (was $10M) — a 3.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether ASLAN Pharmaceuticals is outperforming or lagging.

Tracking ASLN's accounts payable over time shows whether ASLAN Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $9.7M That compares with $10M in the prior-year period — down 3.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has ASLAN Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $9.7M) with ownership activity and broader fundamentals.

ASLAN Pharmaceuticals's accounts payable is $9.7M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.